The Pfizer stake now accounts for 5.2% of Wilsey’s U.S. equity portfolio, placing it outside the fund’s top five holdings.

Pfizer (PFE) closed at $25.24 in the latest trading session, marking a -1.71% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.28% for the day. Elsewhere, the ...

The article " Why AbbVie and Johnson & Johnson Could Outperform Pfizer " first appeared on MarketBeat.

After tanking in early August, the world’s most valuable pharmaceutical stock has roared back with a vengeance. That firm is ...

Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock ...

In a statement announcing the scheme, the FDA said that more than half of the pharmaceuticals distributed in the US are ...

Let's start with one of my favorite ultra-high-yielders, Ares Capital (NASDAQ: ARCC). This stock pays a forward dividend yield of 9.4%. Investing one-third of an initial $100,000 should generate ...

President Trump and members of the cabinet are expected to attend. Federal law enforcement agencies, a new assessment released Thursday, said they are "tracking several threats of unknown credibility" ...

Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...

On Tuesday, Trump announced a deal with Pfizer CEO Albert Bourla to cut drug prices in exchange for relief from planned ...

The VanEck Pharmaceutical exchange-traded fund is on a strong run this week [as news of Pfizer's deal with the Trump ...

European shares logged their best weekly showing in five months on Friday with healthcare and miners leading advances on the ...